Sort   by:  
 Page size 
GenomicsLoss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma
DNA methylation at the 5-position of cytosine (5-mC) is a key epigenetic mark critical for varius biological and pathological processes. 5-mC can be converted to 5-hydroxymethylcytosine (5-hmC) by the Ten-Eleven Translocation (TET) family of DNA hydroxylases. Here we report that "loss of 5-hmC&...
ORGANISM(S): Homo sapiens 
2012-09-18 | E-GEOD-38231 | biostudies-arrayexpress
UnknownLoss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Not available
S-EPMC3770275 | biostudies-literature
ProteomicsVincristine resistance reshapes sphingolipid composition and promotes mitochondrial complex I deficiency in acute myelogenous leukemia
Modifications in sphingolipid (SL) metabolism and mitochondrial bioenergetics are key factors implicated in cancer cell response to chemotherapy, including chemotherapy resistance. Vinca alkaloids such as vincristine (VCR), widely used in cancer treatment, are no exception, as their beneficial actio...
ORGANISM(S): Homo Sapiens (human) 
2022-04-21 | PXD025645 | JPOST Repository
UnknownMultiplexed Assays of Variant Effect and Automated Patch Clamping Improve <i>KCNH2</i>-LQTS Variant Classification and Cardiac Event Risk Stratification.
Not available
S-EPMC11611689 | biostudies-literature
UnknownPathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome.
Not available
S-EPMC8273149 | biostudies-literature
UnknownBeyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinoma.
Not available
S-EPMC12486008 | biostudies-literature
UnknownMCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.
Not available
S-EPMC9035053 | biostudies-literature
UnknownThe EN-TEx resource of multi-tissue personal epigenomes & variant-impact models.
Not available
S-EPMC10074325 | biostudies-literature
UnknownGene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
Not available
S-EPMC9751776 | biostudies-literature
UnknownCCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
Not available
S-EPMC10107112 | biostudies-literature
Sort   by:  
 Page size